Cargando…
XEN45 Gel Stent Combined with Healaflow Injectable Viscoelastic Implant
PURPOSE: To introduce a potential solution for failed glaucoma surgeries by proposing an optional surgical procedure in conjunction with the use of Healaflow (Anteis S.A., Geneva, Switzerland) as a spacer, which may potentially reduce the failure rate. Case Presentation. We present the outcomes of a...
Autores principales: | Villarreal, Eloy, Berkowitz, Eran, Tiosano, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686706/ https://www.ncbi.nlm.nih.gov/pubmed/38033752 http://dx.doi.org/10.1155/2023/7096406 |
Ejemplares similares
-
Efficacy of the XEN45 Implant in Advanced to End-stage Glaucoma Patients
por: Hindi, Isaac, et al.
Publicado: (2022) -
“Culture-positive exogenous endophthalmitis related to XEN45 gel stent implantation”
por: Ng, Aaron W., et al.
Publicado: (2022) -
XEN(®)-63 Compared to XEN(®)-45 Gel Stents to Reduce Intraocular Pressure in Glaucoma
por: Evers, Charlotte, et al.
Publicado: (2023) -
Four-Year Outcome of XEN 45 Gel Stent Implantation in a Swedish Population
por: Busch, Tobias, et al.
Publicado: (2023) -
Intraoperative suprachoroidal hemorrhage during Xen gel stent implantation
por: Liu, James C., et al.
Publicado: (2020)